Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Kindred Biosciences (KIN)

Kindred Biosciences (KIN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 420,524
  • Shares Outstanding, K 45,462
  • Annual Sales, $ 42,160 K
  • Annual Income, $ -21,800 K
  • 60-Month Beta 1.30
  • Price/Sales 9.97
  • Price/Cash Flow N/A
  • Price/Book 5.27
Trade KIN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.03
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/04/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00%
  • Historical Volatility 4.47%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.25
  • Prior Year -0.31
  • Growth Rate Est. (year over year) +45.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.05 +2.21%
on 07/29/21
9.26 -0.11%
on 08/27/21
+0.17 (+1.87%)
since 07/27/21
3-Month
4.64 +99.31%
on 06/01/21
9.28 -0.32%
on 06/17/21
+4.46 (+93.11%)
since 05/27/21
52-Week
3.46 +167.34%
on 11/02/20
9.28 -0.32%
on 06/17/21
+5.30 (+134.18%)
since 08/27/20

Most Recent Stories

More News
Elanco Closes Acquisition of Kindred Biosciences

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has closed the acquisition of Kindred Biosciences. The transaction advances Elanco's access to the fast-growing $1+ billion dermatology...

KIN : 9.25 (+0.11%)
ELAN : 32.44 (-1.16%)
INVESTIGATION: Halper Sadeh LLP Investigates SYKE, MCF, ONEM, KIN; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SYKE : 54.00 (+0.04%)
MCF : 4.69 (-1.26%)
ONEM : 19.51 (-1.18%)
KIN : 9.25 (+0.11%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, SYKE, MNR, and QTS Shareholders About Its Ongoing Investigations

/PRNewswire/ --

KIN : 9.25 (+0.11%)
SYKE : 54.00 (+0.04%)
MNR : 18.74 (-0.69%)
QTS : 77.98 (+0.04%)
SHAREHOLDER ALERT: Monteverde & Associates PC Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / August 16, 2021 / , founder and managing partner at , a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered...

KIN : 9.25 (+0.11%)
ONEM : 19.51 (-1.18%)
SYKE : 54.00 (+0.04%)
INVESTIGATION: Halper Sadeh LLP Investigates BRBS, KIN, MNR, IKNX; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / August 11, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

BRBS : 17.41 (-0.91%)
KIN : 9.25 (+0.11%)
MNR : 18.74 (-0.69%)
IKNX : 27.85 (+1.02%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds SQ, TBIO, KIN, and MNR Shareholders About Its Ongoing Investigations

/PRNewswire/ --

SQ : 243.75 (-5.56%)
TBIO : 37.98 (+1.66%)
KIN : 9.25 (+0.11%)
MNR : 18.74 (-0.69%)
Kindred Bio: Q2 Earnings Snapshot

BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Thursday reported a second-quarter loss of $9.1 million, after reporting a profit in the same period a year earlier.

KIN : 9.25 (+0.11%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates RFL, VNE, ACBI, KIN; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RFL : 35.00 (-2.64%)
VNE : 34.76 (-0.26%)
ACBI : 26.19 (+0.61%)
KIN : 9.25 (+0.11%)
Lifshitz Law Firm, P.C. Announces Investigation of BRBS, IRT, KIN, and MMAC

EQNX::TICKER_START EQNX::TICKER_END

BRBS : 17.41 (-0.91%)
IRT : 20.65 (+0.15%)
KIN : 9.25 (+0.11%)
MMAC : 27.77 (+0.04%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CVA, SWN, KIN, and SHSP Shareholders About Its Ongoing Investigations

/PRNewswire/ --

CVA : 20.11 (+0.10%)
SWN : 5.87 (-0.17%)
KIN : 9.25 (+0.11%)
SHSP : 17.10 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have...

See More

Key Turning Points

3rd Resistance Point 9.28
2nd Resistance Point 9.27
1st Resistance Point 9.26
Last Price 9.25
1st Support Level 9.24
2nd Support Level 9.23
3rd Support Level 9.22

See More

52-Week High 9.28
Last Price 9.25
Fibonacci 61.8% 7.06
Fibonacci 50% 6.37
Fibonacci 38.2% 5.68
52-Week Low 3.46

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar